@article{TCR7216,
author = {Marius Ilié and Paul Hofman},
title = {Expanding opportunities for crizotinib resistance in ALK-positive lung cancer patients},
journal = {Translational Cancer Research},
volume = {5},
number = {2},
year = {2016},
keywords = {},
abstract = {Anaplastic lymphoma kinase (ALK) gene rearrangements are present in 3–7% of patients with non-small cell lung cancer (NSCLC) and are more common among patients with a never/light smoking history, adenocarcinoma histology, a younger age, female gender and in patient with tumors with a wild-type status for the EGFR and KRAS genes (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/7216}
}